Halyard Health, Inc. (NYSE:HYH) saw unusually large options trading on Thursday. Stock traders purchased 727 call options on the stock. This represents an increase of approximately Infinity compared to the average daily volume of 0 call options.

Several analysts have recently issued reports on the company. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday. Stifel Nicolaus reiterated a “buy” rating and set a $52.00 price target on shares of Halyard Health in a research note on Friday. TheStreet downgraded Halyard Health from a “b-” rating to a “c+” rating in a research note on Monday, October 30th. Zacks Investment Research upgraded Halyard Health from a “sell” rating to a “hold” rating in a research note on Thursday, October 19th. Finally, KeyCorp reiterated a “hold” rating on shares of Halyard Health in a research note on Tuesday, October 17th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $44.00.

Halyard Health (HYH) opened at $46.31 on Tuesday. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $2,216.77, a P/E ratio of 22.65, a price-to-earnings-growth ratio of 2.56 and a beta of 1.69. Halyard Health has a twelve month low of $32.60 and a twelve month high of $50.99.

Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.47 by $0.13. The firm had revenue of $401.40 million during the quarter, compared to analysts’ expectations of $394.54 million. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.48 EPS. equities research analysts expect that Halyard Health will post 2.08 earnings per share for the current year.

Institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC acquired a new position in Halyard Health in the 1st quarter valued at approximately $727,000. Malaga Cove Capital LLC raised its holdings in shares of Halyard Health by 1.0% in the 2nd quarter. Malaga Cove Capital LLC now owns 56,760 shares of the medical instruments supplier’s stock worth $2,243,000 after buying an additional 568 shares in the last quarter. KCG Holdings Inc. acquired a new position in shares of Halyard Health in the 1st quarter worth approximately $369,000. Koch Industries Inc. acquired a new position in shares of Halyard Health in the 2nd quarter worth approximately $297,000. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of Halyard Health by 3.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 797,993 shares of the medical instruments supplier’s stock worth $31,346,000 after buying an additional 27,421 shares in the last quarter. 91.08% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Traders Purchase High Volume of Call Options on Halyard Health (HYH)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/traders-purchase-high-volume-of-call-options-on-halyard-health-hyh/1684072.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.